Effects of Amyloid Precursor Protein 17 Peptide on the Protection of Diabetic Encephalopathy and Improvement of Glycol Metabolism in the Diabetic Rat
Researchers have proposed that amyloid precursor protein 17 peptide (APP17 peptide), an active fragment of amyloid precursor protein (APP) in the nervous system, has therapeutic effects on neurodegeneration. Diabetic encephalopathy (DE) is a neurological disease caused by diabetes. Here we use multi...
Saved in:
| Main Authors: | Heng Meng, Duo Zhang, Haishan Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2013/689841 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of the Insulin-Like Growth Factor Type 1 Receptor in the Pathogenesis of Diabetic Encephalopathy
by: Duo Zhang, et al.
Published: (2015-01-01) -
Diabetic encephalopathy
by: I. A. Strokov, et al.
Published: (2014-01-01) -
Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.
by: Victoria Lewis, et al.
Published: (2012-01-01) -
AMPA receptor activation promotes non-amyloidogenic amyloid precursor protein processing and suppresses neuronal amyloid-β production.
by: Sarah E Hoey, et al.
Published: (2013-01-01) -
Consequences of Inhibiting Amyloid Precursor Protein Processing Enzymes on Synaptic Function and Plasticity
by: Hui Wang, et al.
Published: (2012-01-01)